ANTIMETHANOGENE LOVASTATIN-ANALOGA ODER -DERIVATE UND VERWENDUNGEN DAVON

European patent · EP3277274 · Deleted

Register entry

Publication number
EP3277274
Application number
EP16774176
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Mar 31, 2016
Published
Feb 7, 2018
Granted
Jun 12, 2024
Deleted
Oct 23, 2025
Reason
Annual fee unpaid
IPC classes
A61K 31/351 (2006.01)
A61K 31/366 (2006.01)
A61P 1/04 (2006.01)
Priority
US 201562141413 P 01.04.2015
PCT application
PCT/US2016/025214 31.03.2016
PCT publication
WO2016/161085 06.10.2016
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 23, 2025

    Deleted, fee unpaid

    Status of protective title
    Active → Cancelled
    Cancellation date
    23.10.2025
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 23.10.2025

  2. Apr 23, 2025

    Change

    Published in Swissreg on 23.04.2025

  3. Jun 12, 2024

    Granted

    Published in Swissreg on 12.06.2024

Parties

Holder

Cedars-Sinai Medical Center

8700 Beverly Boulevard, Los Angeles, CA 90048, US

Synthetic Biologics, Inc.

155 Gibbs Street Suite 412, Rockville, MD 20850, US

Inventor

WACHER, Vince

Rockville, MD 20850, US

PIMENTEL, Mark

Los Angeles, CA 90034, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.